Accès ouvert
2026
other
OpenAlex
Ryan Robb, Sarah E. Ackermann, Seamus Degan, Khalilah E. Taylor et autres
Downregulation of macropinocytosis is not sustained following genetic loss of KRAS in KRAS-mutant PDAC cell lines. A, Representative images of macropinosomes labeled with FITC–dextran (green) and nuclear DAPI stain (blue) in indicated KRAS-mutant PDAC cells transiently transfected with an siRNA oligonucleotide (10 …
Accès ouvert
2026
other
OpenAlex
Ryan Robb, Sarah E. Ackermann, Seamus Degan, Khalilah E. Taylor et autres
PDAC cell lines with acquired resistance to pharmacologic inhibitors of RAS exhibit enhanced macropinocytosis. A, Schematic diagram showing the experimental design for generating cell lines with acquired resistance to MRTX1133 (G12Di) and RMC7797 (RASi). B, Representative images of macropinosomes labeled with FITC–dextran …
Accès ouvert
2026
other
OpenAlex
Ryan Robb, Sarah E. Ackermann, Seamus Degan, Khalilah E. Taylor et autres
Upregulated macropinocytosis in RAS inhibitor-resistant cell lines is associated with increased uptake of and sensitivity to albumin-bound paclitaxel compared with free drug. A, Schematic diagram highlighting the differential routes through which free paclitaxel and albumin-bound nab-paclitaxel enter the cell. B, Representative images …
Accès ouvert
2026
other
OpenAlex
Ryan Robb, Sarah E. Ackermann, Seamus Degan, Khalilah E. Taylor et autres
KRAS suppression results in a transient reduction in macropinocytosis
Accès ouvert
2026
other
OpenAlex
Ryan Robb, Sarah E. Ackermann, Seamus Degan, Khalilah E. Taylor et autres
PDAC cell lines display both PI3K-dependent and -independent signaling supporting macropinocytosis. A, Schematic diagram delineating the experimental set-up for RPPA analysis and parallel validation via immunoblotting. B, RPPA Pearson correlation coefficients comparing cell lines and treatments based on the AUC following dimensionality …
Accès ouvert
2026
other
OpenAlex
Ryan Robb, Sarah E. Ackermann, Seamus Degan, Khalilah E. Taylor et autres
Different RAS inhibitor-resistant PDAC cell lines activate RAC via distinct pathways to upregulate macropinocytosis. A, Diagram of signaling pathways relevant to macropinocytosis that focuses on the central role of RAC activation downstream of RAS, PI3K, and FAK signaling. B, Immunoblotting of indicated …
Accès ouvert
2026
other
OpenAlex
Ryan Robb, Sarah E. Ackermann, Seamus Degan, Khalilah E. Taylor et autres
Pictilisib treatment impairs growth and PI3K signaling in PDAC cell lines
Accès ouvert
2026
other
OpenAlex
Ryan Robb, Sarah E. Ackermann, Seamus Degan, Khalilah E. Taylor et autres
Pictilisib (PI3Ki) treatment decreases PI3K-mediated signaling in PDAC cell lines
Accès ouvert
2026
other
OpenAlex
Ryan Robb, Sarah E. Ackermann, Seamus Degan, Khalilah E. Taylor et autres
Prolonged RAS pathway inhibition in KRAS-mutant PDAC cells results in increased macropinocytosis
Accès ouvert
2026
other
OpenAlex
Ryan Robb, Sarah E. Ackermann, Seamus Degan, Khalilah E. Taylor et autres
PDAC cell lines display both PI3K-dependent and -independent signaling supporting macropinocytosis
Accès ouvert
2026
other
OpenAlex
Ryan Robb, Sarah E. Ackermann, Seamus Degan, Khalilah E. Taylor et autres
A subset of RASi-resistant PDAC cell lines activates YAP and/or TAZ to upregulate macropinocytosis
Accès ouvert
2026
other
OpenAlex
Ryan Robb, Sarah E. Ackermann, Seamus Degan, Khalilah E. Taylor et autres
RPPA analysis of PDAC cell line panel treated with RAS ERK MAPK inhibitors for 24 to 168 hours